Kyprolis is given by intravenous (IV) infusion, usually in a clinic or hospital setting. The dosage and schedule depend on various factors, including the patient's health condition, the stage of the cancer, and whether it is being used in combination with other cancer therapies. It is often administered in cycles, allowing periods of rest between doses to help the body recover.
